Sanofi-Aventis (France)

Sanofi-Aventis is currently the world's #4 drug company, but the market leader in Europe. It was formed in 2004 from the hostile takeover of French pharmaceutical giant Aventis by smaller rival Sanofi-Synthelabo. A key factor in the takeover was the controversial role played by the French government which successfully steered Aventis away from a merger with Swiss-based Novartis in order to create a national champion that would compete more effectively with Pfizer and GlaxoSmithKline. In 2007, the group was reported to have commenced merger talks with Bristol-Myers Squibb, which has US rights to Sanofi-Aventis's Plavix drug. No deal has yet materialised. Advertising Age estimated global measured advertising expenditure of $318m in 2007, making Sanofi-Aventis the world's #98 advertiser. Click here to access the Adbrands profile (subscribers only); or subscribe to Adbrands.net here. Adbrands Company Profiles provide a detailed analysis of the history and current operations of leading advertisers, agencies and brands worldwide, and include a critical summary which identifies key strengths and weaknesses. Adbrands Account Assignments tracks account management for the world's leading brands and companies, including details of which advertising agency handles which accounts in which countries for major markets.

Advertising: Which agencies handle advertising for Sanofi-Aventis? The searchable account assignments database is available to full subscribers to Adbrands.net premium services. Click here for subscription information.

Competitors: see Pharmaceutical & Healthcare Sector index for other companies

Subscribers may access the following website links:

Sanofi-Aventis website

Plavix	Ambien
Ketek	Eloxatin
Xatral	Merial
Allegra	Taxotere
Lovenox	Amaryl
Lantus	Actonel
Copaxone	Nasacort
Sanofi Pasteur	Yves Rocher

Click HERE to subscribe to Adbrands.net and access the profile and website links